drugset / Trial / NCT06817096

Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza

NCT06817096

Phase 3 Not yet recruiting 340 enrolled Azidus Brasil Farmoquimica S.A. · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

2\. Participants will: * Take nitazoxanide 600mg (or placebo) orally twice daily for 7 days, for a total of 14 doses. * Visit the clinic on the 7th day of treatment for a check-up and safety tests. * Keep a diary of their symptoms and other medications used

Timeline

Start
2025-02
Primary completion
2026-12
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitazoxanide Other / unclassified 600 mg Oral

Indications